Train Babcock Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Train Babcock Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,969	Closed	-$351K	–	120
2016 Q4	$351K	Hold	3,969	–	–	0.14%	93
2016 Q3	$383K	Buy	3,969 +15	+0.4%	+$1.43K	0.15%	91
2016 Q2	$339K	Buy	3,954 +12	+0.3%	+$1.08K	0.13%	94
2016 Q1	$343K	Hold	3,942	–	–	0.14%	93
2015 Q4	$445K	Buy	3,942 +1,500	+61%	+$163K	0.17%	87
2015 Q3	$247K	Hold	2,442	–	–	0.09%	114
2015 Q2	$300K	Hold	2,442	–	–	0.09%	108
2015 Q1	$280K	Hold	2,442	–	–	0.09%	114
2014 Q4	$247K	Hold	2,442	–	–	0.08%	115
2014 Q3	$223K	Hold	2,442	–	–	0.08%	114
2014 Q2	$209K	Buy	+2,442	New	+$192K	0.07%	120

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Train Babcock Advisors's IBB Position: Q1 2017 in Review

Train Babcock Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 3,969 shares — an estimated $351K sold.

Train Babcock Advisors first reported a position in IBB in Q2 2014 and held it in 11 quarters. The position peaked at $445K in Q4 2015. 521 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

Train Babcock Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
Train Babcock Advisors sold 3,969 iShares Biotechnology ETF shares in Q1 2017, an estimated $351K.
Train Babcock Advisors first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 11 quarters.
Train Babcock Advisors's iShares Biotechnology ETF position peaked at $445K in Q4 2015.
521 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Train Babcock Advisors's 13F filing for Q1 2017, filed 1 May 2017.